IMAX Corporation

NYSE:IMAX Aktierapport

Börsvärde: US$2.2b

IMAX Förvaltning

Förvaltning kriterier kontrolleras 3/4

IMAX VD är Rich Gelfond, utsedd i May 2026, har en mandatperiod på 32.17 år. totala årliga ersättningen är $ 8.66M, bestående av 13.9% lön 86.1% bonusar, inklusive företagsaktier och optioner. äger direkt 1.39% av företagets aktier, värda $ 31.07M. Den genomsnittliga mandatperioden för ledningsgruppen och styrelsen är 5.1 år respektive 10.9 år.

Viktig information

Rich Gelfond

Verkställande direktör

US$8.7m

Total ersättning

VD-lön i procent13.86%
Anställning som VDno data
Ägande av VD1.4%
Ledningens genomsnittliga anställningstid5.1yrs
Styrelsens genomsnittliga mandatperiod10.9yrs

Senaste uppdateringar av ledningen

Recent updates

Seeking Alpha 19h

IMAX: Price Surge In Line With Buyout Expectations, But It's Not Pure Roses

Summary IMAX Corporation faces inflation-driven headwinds, but its diversified, quality-focused business model and digital adaptability provide resilience. Q1 2026 revenue declined 6% YoY to $81.38M, with operating margin dropping to 12.2% amid rising costs and softer demand. IMAX’s strategic partnerships with streaming platforms and customizable theater offerings help maintain demand and mitigate competitive and inflationary pressures. With $146M in cash, IMAX’s liquidity remains robust, but at ~$40 per share, valuation appears rich and already prices in potential buyout premiums. Read the full article on Seeking Alpha
Uppdatering av berättelse May 02

IMAX: Global Premium Footprint Expansion Will Shape Future Earnings Power

The analyst price target for IMAX edges higher to about $41.09 from $41.00 as analysts incorporate mixed target moves across firms, modest adjustments to revenue growth and margin assumptions, and slightly higher future P/E expectations. Analyst Commentary Recent Street research on IMAX presents a mixed picture, with several firms lifting price targets while a smaller group trims expectations and highlights areas of risk.
Uppdatering av berättelse Apr 18

IMAX: Premium Theatrical Formats And Strong Box Office Will Drive Future Upside

The IMAX analyst price target edges higher to about $45.27 from $45.00, as analysts factor in recent target raises tied to strong Q4 results, higher box office activity, robust system installs, and expectations for continued importance within the global theatrical ecosystem. Analyst Commentary Recent Street research on IMAX clusters around higher price targets and generally positive reactions to the latest quarterly results, box office trends, and system installation activity.
Uppdatering av berättelse Apr 04

IMAX: Future Earnings Base And Global Footprint Frame Balanced Opportunity And Risk

Narrative Update: IMAX Analyst Price Target Shift The analyst price target for IMAX has moved to $41.00. Analysts cite record share gains, accelerating international expansion, strong Q4 and full-year revenue and margins, and continued outperformance versus consensus as key factors influencing their updated views.
Uppdatering av berättelse Mar 21

IMAX: Record Box Office And Premium Format Position Will Support Future Upside

The analyst price target for IMAX is raised by about $1 to $45.00, as analysts factor in higher margin expectations, a lower assumed future P/E multiple, and recent research citing strong quarterly results, record box office driven revenue, and a stronger position in the global theatrical ecosystem. Analyst Commentary Recent research updates show a cluster of target price increases for IMAX, with analysts reacting to reported results, box office trends, and the company’s role in premium theatrical formats.
Uppdatering av berättelse Mar 06

IMAX: Future Earnings Base And International Footprint Suggest Balanced Opportunity And Risk

The Analyst Price Target for IMAX has increased from $22.04 to $41.00. This reflects analysts' views that recent record revenue, strong margins, higher box office activity and an expanding international footprint support a higher assumed profit margin and P/E multiple in updated models.
Uppdatering av berättelse Feb 20

IMAX: Live Sports And Content Partnerships Will Support Future Upside

Analysts have maintained their $47.00 price target on IMAX, citing updated assumptions around discount rate, revenue growth, profit margin, and a higher future P/E multiple. They also highlight broader sector risks such as high development costs, dependence on single assets, and limited near term catalysts in comparable coverage.
Uppdatering av berättelse Feb 05

IMAX: Future Slate And Execution Will Support Expanded Premium Format Opportunities

Analysts have inched their price target for IMAX higher to approximately US$44.09 from about US$43.73, reflecting updated assumptions around revenue growth, profit margins and future P/E levels. Analyst Commentary Analysts have updated their IMAX models around revenue, margins and future P/E levels, which feeds directly into the small lift in the price target to about US$44.09.
Uppdatering av berättelse Jan 22

IMAX: Future Slate And Profit Execution Will Support Measured Upside Potential

Analysts have lifted their IMAX fair value estimate from about US$38.81 to roughly US$43.73 per share, citing updated assumptions for revenue growth, profit margins and a lower future P/E that together support a higher price target. Analyst Commentary Analysts reviewing IMAX after the updated fair value estimate are split between what could support the higher valuation and what might limit upside if execution falls short.
Uppdatering av berättelse Jan 08

IMAX: Premium Screens And Local Language Hits Will Support Future Upside

Analysts have raised their price target on IMAX to $40 from $36, citing record Q3 global box office results, an increasing market share, strong local language titles, and faster-than-expected network expansion in markets with above-average revenue per screen. Analyst Commentary Bullish analysts point to IMAX's recent record Q3 global box office results and its second highest quarterly gross as key supports for their updated views, highlighting what they see as solid execution across the business.
Uppdatering av berättelse Dec 21

IMAX: Expanding Premium Network Will Drive Stronger Box Office Performance

Analysts have lifted their price target on IMAX to approximately $47 from about $38, citing accelerating network expansion into higher revenue markets, record and resilient box office performance, and an expectation for stronger, more profitable growth that, in their view, supports a lower forward earnings multiple versus historical levels. Analyst Commentary Bullish analysts have recently highlighted IMAX as one of the stronger execution stories in the theatrical ecosystem, pointing to a mix of box office outperformance, premium market exposure, and disciplined capital deployment as key supports for higher valuation.
Uppdatering av berättelse Dec 07

IMAX: Future Slate And Premium Screen Expansion Will Drive Measured Performance

We raise our IMAX price target to approximately $39 from about $37, as analysts highlight record Q3 box office performance, accelerating high value screen expansion, and a robust Q4 film slate that together support modestly stronger growth and valuation assumptions. Analyst Commentary Recent Street commentary on IMAX has tilted clearly positive, with multiple firms raising price targets in response to stronger than expected operating trends and an improving growth outlook.
Uppdatering av berättelse Nov 22

IMAX: Future Box Office Releases And Network Expansion Will Shape Performance

IMAX's analyst price target has increased significantly, rising from $36 to $37 per share to $40 to $42 per share, as analysts cite strong quarterly box office results, ongoing network expansion, and promising upcoming film releases as key drivers of growth. Analyst Commentary Recent updates from street research provide insights into the positive momentum behind IMAX's upgraded price targets, as well as areas of continued scrutiny among analysts.
Uppdatering av berättelse Nov 01

IMAX: Accelerating Network Expansion Will Drive Global Box Office Performance

The analyst consensus price target for IMAX has increased from approximately $36.45 to $37.18. Analysts highlight strong box office performance and accelerating network expansion as key drivers for the upward revision.
Uppdatering av berättelse Oct 18

North America And Japan Installations Will Strengthen Premium Entertainment

Analysts have raised their price target for IMAX from approximately $34.36 to $36.45. They cite stronger box office performance, accelerating network expansion, and improved margins as key factors supporting the higher valuation.
Uppdatering av berättelse Oct 04

North America And Japan Installations Will Strengthen Premium Entertainment

IMAX's analyst price target has been raised from $31 to $38, reflecting higher expected margins and valuation multiples according to analysts. Analyst Commentary Analyst sentiment toward IMAX has recently shifted, leading to an upward revision of the company's price target.
Analysartikel Sep 09

Earnings Tell The Story For IMAX Corporation (NYSE:IMAX) As Its Stock Soars 25%

IMAX Corporation ( NYSE:IMAX ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...
Analysartikel Aug 04

Is Now An Opportune Moment To Examine IMAX Corporation (NYSE:IMAX)?

IMAX Corporation ( NYSE:IMAX ), is not the largest company out there, but it received a lot of attention from a...
Analysartikel Jun 13

An Intrinsic Calculation For IMAX Corporation (NYSE:IMAX) Suggests It's 32% Undervalued

Key Insights IMAX's estimated fair value is US$42.15 based on 2 Stage Free Cash Flow to Equity Current share price of...
Analysartikel May 17

Market Participants Recognise IMAX Corporation's (NYSE:IMAX) Earnings Pushing Shares 25% Higher

IMAX Corporation ( NYSE:IMAX ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...
Analysartikel May 02

IMAX's (NYSE:IMAX) Soft Earnings Are Actually Better Than They Appear

Shareholders appeared unconcerned with IMAX Corporation's ( NYSE:IMAX ) lackluster earnings report last week. We think...
Analysartikel Apr 19

Should You Investigate IMAX Corporation (NYSE:IMAX) At US$22.45?

While IMAX Corporation ( NYSE:IMAX ) might not have the largest market cap around , it saw significant share price...
Analysartikel Apr 04

Here's What's Concerning About IMAX's (NYSE:IMAX) Returns On Capital

When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...
Analysartikel Mar 15

We Think IMAX (NYSE:IMAX) Can Stay On Top Of Its Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Seeking Alpha Mar 09

IMAX Corporation: Unlocking Asymmetric Gains In Premium Cinema

Summary IMAX remains the leading choice for premium cinema experiences, generating outsized box office returns despite a small footprint of 1% of total screens. The company’s success in China is encouraging, but future box office results may be dampened due to a lack of new local content. IMAX’s global expansion in local language partnerships could face higher costs and challenges adapting to diverse filmmaking workflows. While financially recovered from the pandemic, IMAX’s growth trajectory appears plateaued, with flat revenue and cash flow projections. Given the overvaluation of IMAX stock, investors should hold and wait for a significant price retracement before considering entry. Read the full article on Seeking Alpha
Analysartikel Jan 08

Is Now The Time To Look At Buying IMAX Corporation (NYSE:IMAX)?

While IMAX Corporation ( NYSE:IMAX ) might not have the largest market cap around , it led the NYSE gainers with a...
Seeking Alpha Dec 24

IMAX Corporation: Overseas Growth Opportunities

Summary IMAX Corporation's stock has surged 60% since its June lows, but there has been a notable uptick in insider selling in December. IMAX Corporation has considerable long-term growth opportunities and should benefit from an expected well-received movie slate in 2025. An analysis of IMAX Corporation follows in the paragraphs below. Read the full article on Seeking Alpha
Analysartikel Dec 10

IMAX (NYSE:IMAX) Has Some Difficulty Using Its Capital Effectively

When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...
Analysartikel Nov 23

IMAX Corporation (NYSE:IMAX) Shares Could Be 44% Below Their Intrinsic Value Estimate

Key Insights IMAX's estimated fair value is US$45.02 based on 2 Stage Free Cash Flow to Equity IMAX's US$25.19 share...
Analysartikel Nov 07

After Leaping 26% IMAX Corporation (NYSE:IMAX) Shares Are Not Flying Under The Radar

The IMAX Corporation ( NYSE:IMAX ) share price has done very well over the last month, posting an excellent gain of...
Analysartikel Oct 31

Here's Why IMAX (NYSE:IMAX) Can Manage Its Debt Responsibly

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysartikel Oct 13

If EPS Growth Is Important To You, IMAX (NYSE:IMAX) Presents An Opportunity

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Seeking Alpha Oct 10

IMAX Corporation: Undervalued Relative To Revenue Growth And Margin Expansion Potential

Summary IMAX Corporation has a long growth runway in international markets, as the foreign markets' IMAX theater network penetration rate is lower than that for the US. IMAX can achieve higher profit margins in the future with rising top line contribution from alternative content that boosts the company's overall capacity utilization rate. IMAX stock is trading at below 1 times PEG, which implies that it is undervalued relative to its financial improvement potential. Read the full article on Seeking Alpha
Analysartikel Sep 30

When Should You Buy IMAX Corporation (NYSE:IMAX)?

IMAX Corporation ( NYSE:IMAX ), might not be a large cap stock, but it received a lot of attention from a substantial...
User avatar
Ny berättelse Sep 24

Calculated Global Expansion And Innovative Content Slate Set To Propel Growth

IMAX's strategic expansions and landmark deals in global markets promise substantial revenue growth through new installations and high-profile film releases.
Analysartikel Aug 23

Returns On Capital At IMAX (NYSE:IMAX) Paint A Concerning Picture

Ignoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...
Seeking Alpha Jul 30

IMAX Corporation: Upbeat Mid-Term Outlook After Great Q2 Signings

Summary IMAX Corporation provides technology to movie theaters bringing an immersive experience, in part protecting the company from the rise of digital streaming platforms. After consistent backlog declines, IMAX finally reported great new signings in Q2, providing a great midterm growth outlook with a great new blockbuster movie pipeline. While IMAX's midterm growth outlook is great, the stock already prices in good growth, mitigating a very significant investment opportunity from the upbeat outlook. Read the full article on Seeking Alpha
Analysartikel Jul 26

Pinning Down IMAX Corporation's (NYSE:IMAX) P/S Is Difficult Right Now

When you see that almost half of the companies in the Entertainment industry in the United States have price-to-sales...
Analysartikel Jun 19

Is IMAX (NYSE:IMAX) A Risky Investment?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysartikel May 22

Is It Too Late To Consider Buying IMAX Corporation (NYSE:IMAX)?

IMAX Corporation ( NYSE:IMAX ), might not be a large cap stock, but it saw a decent share price growth of 18% on the...
Seeking Alpha Apr 08

IMAX Corporation: Good Reasons To Be Bullish

Summary IMAX Corporation's short-to-medium term performance is expected to be good, as the company is grabbing a bigger slice of the global box office and gaining recognition from the film industry's players. For the long term, IMAX is actively diversifying into non-film content like events and documentaries to reduce its reliance on movies over time. I view IMAX stock as a good investment candidate, as there are multiple positive factors for the shares. Read the full article on Seeking Alpha

Analys av ersättningar till VD

Hur har Rich Gelfond:s ersättning förändrats jämfört med IMAX:s resultat?
DatumTotal ersättningLönFöretagets resultat
Mar 31 2026n/an/a

US$37m

Dec 31 2025US$9mUS$1m

US$35m

Sep 30 2025n/an/a

US$40m

Jun 30 2025n/an/a

US$33m

Mar 31 2025n/an/a

US$25m

Dec 31 2024US$8mUS$1m

US$26m

Sep 30 2024n/an/a

US$23m

Jun 30 2024n/an/a

US$21m

Mar 31 2024n/an/a

US$26m

Dec 31 2023US$9mUS$1m

US$25m

Sep 30 2023n/an/a

US$25m

Jun 30 2023n/an/a

US$4m

Mar 31 2023n/an/a

-US$7m

Dec 31 2022US$8mUS$1m

-US$23m

Sep 30 2022n/an/a

-US$15m

Jun 30 2022n/an/a

-US$15m

Mar 31 2022n/an/a

-US$21m

Dec 31 2021US$9mUS$1m

-US$22m

Sep 30 2021n/an/a

-US$54m

Jun 30 2021n/an/a

-US$93m

Mar 31 2021n/an/a

-US$109m

Dec 31 2020US$7mUS$1m

-US$144m

Sep 30 2020n/an/a

-US$104m

Jun 30 2020n/an/a

-US$48m

Mar 31 2020n/an/a

-US$11m

Dec 31 2019US$7mUS$1m

US$47m

Ersättning vs marknad: Rich s total kompensation ($USD 8.66M ) är över genomsnittet för företag av liknande storlek på US marknaden ($USD 5.45M ).

Ersättning vs inkomst: Ersättningen från Rich har varit i linje med företagets resultat under det senaste året.


VD OCH KONCERNCHEF

Rich Gelfond (69 yo)

no data
Anställning
US$8,655,929
Kompensation

Mr. Richard Lewis Gelfond, also known as Rich, has been the Chief Executive Officer at IMAX Corporation since April 1, 2009. He serves as the Co-Chief Executive Officer and Co-Chairman of Clarion Capital P...


Ledningsgrupp

NamnPositionAnställningKompensationÄgarskap
Richard Gelfond
CEO & Directorno dataUS$8.66m1.39%
$ 31.1m
Natasha Fernandes
Executive VP & CFO4yrsUS$1.70m0.10%
$ 2.3m
Robert Lister
Chief Legal Officer & Senior EVP14.3yrsUS$2.91m0.37%
$ 8.3m
Anne Globe
Chief Marketing Officer2.3yrsUS$2.06m0.034%
$ 754.3k
Mark Welton
President of IMAX Global Theatres14.6yrsUS$2.62m0.31%
$ 7.0m
Jose Zlatar
Senior VP of Finance & Principal Accounting Officer1.1yrsinga uppgifter0.0020%
$ 44.0k
Heather Anthony
Head of Enterprise Transformation10.3yrsinga uppgifteringa uppgifter
Pablo Calamera
Executive VP & CTO6.3yrsinga uppgifter0.11%
$ 2.4m
Jennifer Horsley
Senior VP & Head of Investor Relations3.7yrsinga uppgifteringa uppgifter
Mark Jafar
Global Head of Corporate Communications6.9yrsinga uppgifteringa uppgifter
Michele Golden
Executive VP & Chief People Officer3.7yrsinga uppgifter0.069%
$ 1.5m
Edward MacNeil
Senior Vice President of Finance24.7yrsUS$460.51kinga uppgifter
5.1yrs
Genomsnittlig anställningstid
58yo
Genomsnittlig ålder

Erfaren ledning: IMAX s ledningsgrupp är erfaren och erfaren ( 5.1 års genomsnittlig anställning).


Styrelseledamöter

NamnPositionAnställningKompensationÄgarskap
Richard Gelfond
CEO & Director32.2yrsUS$8.66m1.39%
$ 31.1m
Dana Settle
Independent Director10.8yrsUS$187.48k0.12%
$ 2.7m
Michael I. MacMillan
Independent Director12.9yrsUS$189.98k0.069%
$ 1.5m
Eric Demirian
Independent Director15.7yrsUS$199.98k0.067%
$ 1.5m
Kevin Douglas
Independent Director9.6yrsUS$192.48k13.39%
$ 299.1m
David Leebron
Lead Independent Director22.7yrsUS$199.98k0.23%
$ 5.2m
Darren Throop
Independent Chairman of the Board10.9yrsUS$282.48k0.066%
$ 1.5m
Gail Berman
Independent Director3.2yrsUS$182.48k0.035%
$ 779.3k
Jennifer Wong
Independent Director3.2yrsUS$184.98k0.035%
$ 779.3k
Stephen Pamon
Independent Director4.9yrsUS$187.48k0.058%
$ 1.3m
10.9yrs
Genomsnittlig anställningstid
64yo
Genomsnittlig ålder

Erfaren styrelse: IMAX s styrelse är rutinerade och erfaren ( 10.9 års genomsnittlig mandatperiod).


Företagsanalys och finansiella data Status

UppgifterSenast uppdaterad (UTC-tid)
Analys av företag2026/05/27 08:20
Aktiekurs vid dagens slut2026/05/27 00:00
Intäkter2026/03/31
Årlig intjäning2025/12/31

Datakällor

Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.

PaketUppgifterTidsramExempel US-källa
Företagets finansiella ställning10 år
  • Resultaträkning
  • Kassaflödesanalys
  • Balansräkning
Analytikernas konsensusuppskattningar+3 år
  • Prognos för finansiella poster
  • Analytikernas prismål
Marknadspriser30 år
  • Aktiekurser
  • Utdelningar, splittar och åtgärder
Ägarskap10 år
  • Största aktieägare
  • Insiderhandel
Förvaltning10 år
  • Ledningsgrupp
  • Styrelse och verkställande direktörer
Viktiga utvecklingstendenser10 år
  • Företagsmeddelanden

* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.

Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.

Analysmodell och snöflinga

Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.

Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.

Industri- och sektormått

Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.

Källor för analytiker

IMAX Corporation bevakas av 20 analytiker. 11 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.

AnalytikerInstitution
Marla BackerAscendiant Capital Markets LLC
David McFadgenATB Cormark Historical (Cormark Securities)
Patrick ShollBarrington Research Associates, Inc.